Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2007Heart

Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement

View Full Paper
Ask AI
Bookmark
Share

Why the study?

What are the clinical indications for genetic testing in familial sudden cardiac death syndromes?

Population

Individuals and families at risk for familial sudden cardiac death syndromes

Design

Guideline

Discussion

Loading...

Member takes

Implication

May support genetic evaluation after young sudden death; leaves open optimal testing yield and family management.

Structured PICO

What are the clinical indications for genetic testing in familial sudden cardiac death syndromes?

P
Population
Individuals and families at risk for familial sudden cardiac death syndromes
I
Intervention
Genetic testing
O
Outcome
Recommendations regarding clinical indications for genetic testing

This position statement provides evidence-based recommendations for the clinical use of genetic testing in families affected by sudden cardiac death syndromes.

Cite This Study

A 2007 study studied this question.

synapsesocial.com/papers/6a90d901504d7cdc493e7607https://doi.org/10.1136/hrt.2007.127761
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Genetic Analyses in Cardiology2006 · 96 citations
  2. 2<i>RYR2</i> and <i>CASQ2</i> Mutations in Patients Suffering From Catecholaminergic Polymorphic Ventricular Tachycardia2003 · 45 citations
  3. 3Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death2002 · 359 citations
  4. 4Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)2002 · 541 citations